KEGG   DRUG: ZanolimumabHelp
Entry
D06356                      Drug                                   

Name
Zanolimumab (USAN/INN)
Efficacy
Antineoplastic, Antirheumatic, Anti-CD4 antibody
Comment
Monoclonal antibody
Treatment of rheumatoid arthritis, psoriasis, cutaneous and peripheral T-cell lymphoma
Target
CD4 [HSA:920] [KO:K06454]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04514  Cell adhesion molecules (CAMs)
Brite
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Other cell surface molecules
   CD molecules
    CD4
     D06356  Zanolimumab (USAN/INN)
BRITE hierarchy
Other DBs
CAS: 652153-01-0
PubChem: 47208013
NIKKAJI: J2.415.692C
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system